In contrast to our results, Song et al. study on colorectal cancer found that RCC2 or p53 deficiency triggers Rac1 activation, and they also established that p53 and RCC2 deficiency promotes random cell migration and loss of RCC2 facilitated tumor metastasis in vivo. This evidence concerns the gene RCC2 and colorectal cancer.